These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12904111)

  • 1. A review of hepatitis B vaccination.
    Geier MR; Geier DA; Zahalsky AC
    Expert Opin Drug Saf; 2003 Mar; 2(2):113-22. PubMed ID: 12904111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B vaccination safety.
    Geier MR; Geier DA
    Ann Pharmacother; 2002 Mar; 36(3):370-4. PubMed ID: 11895045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005-2015.
    Haber P; Moro PL; Ng C; Lewis PW; Hibbs B; Schillie SF; Nelson NP; Li R; Stewart B; Cano MV
    Vaccine; 2018 Jan; 36(4):559-564. PubMed ID: 29241647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B vaccination and adult associated gastrointestinal reactions: a follow-up analysis.
    Geier DA; Geier MR
    Hepatogastroenterology; 2002; 49(48):1571-5. PubMed ID: 12397738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the safety of hepatitis B vaccination during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 1990-2016.
    Moro PL; Zheteyeva Y; Barash F; Lewis P; Cano M
    Vaccine; 2018 Jan; 36(1):50-54. PubMed ID: 29174107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
    Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
    Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
    Van Damme P; Van Herck K
    Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis on the adverse events following immunization of 10 infants death after hepatitis B vaccination].
    Wang FZ; Cui FQ; Liu DW
    Zhongguo Yi Miao He Mian Yi; 2009 Feb; 15(1):52-7. PubMed ID: 20077677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization.
    Losonsky GA; Wasserman SS; Stephens I; Mahoney F; Armstrong P; Gumpper K; Dulkerian S; West DJ; Gewolb IH
    Pediatrics; 1999 Feb; 103(2):E14. PubMed ID: 9925860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review.
    Geier MR; Geier DA
    Clin Exp Rheumatol; 2004; 22(6):749-55. PubMed ID: 15638050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B immunisation in persons not previously exposed to hepatitis B or with unknown exposure status.
    Mathew JL; El Dib R; Mathew PJ; Boxall EH; Brok J
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006481. PubMed ID: 18677780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of immunisation and adverse events following vaccination against hepatitis B.
    Duclos P
    Expert Opin Drug Saf; 2003 May; 2(3):225-31. PubMed ID: 12904102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining hepatitis A and B vaccination in children and adolescents.
    Van Damme P; Van der Wielen M
    Vaccine; 2001 Mar; 19(17-19):2407-12. PubMed ID: 11257370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults.
    Hernández-Bernal F; Aguilar-Betancourt A; Aljovin V; Arias G; Valenzuela C; de Alejo KP; Hernández K; Oquendo O; Figueredo N; Figueroa N; Musacchio A; Véliz G; García E; Mollineda AD; Juvier AI; Trujillo J; Delahanty A; Ortega D; Cinza Z; González VL
    Hum Vaccin; 2011 Oct; 7(10):1026-36. PubMed ID: 21941089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case-control study of serious autoimmune adverse events following hepatitis B immunization.
    Geier DA; Geier MR
    Autoimmunity; 2005 Jun; 38(4):295-301. PubMed ID: 16206512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of a universal, school-based hepatitis B vaccination program.
    Dobson S; Scheifele D; Bell A
    JAMA; 1995 Oct; 274(15):1209-13. PubMed ID: 7563510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of a high-dose hepatitis B vaccine among patients receiving methadone maintenance treatment: A randomized, double-blinded, parallel-controlled trial.
    Shi J; Feng Y; Gao L; Feng D; Yao T; Shi S; Zhang Y; Liang X; Wang S
    Vaccine; 2017 Apr; 35(18):2443-2448. PubMed ID: 28343774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination.
    Young MD; Gooch WM; Zuckerman AJ; Du W; Dickson B; Maddrey WC
    J Med Virol; 2001 Jul; 64(3):290-8. PubMed ID: 11424117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A one year followup of chronic arthritis following rubella and hepatitis B vaccination based upon analysis of the Vaccine Adverse Events Reporting System (VAERS) database.
    Geier DA; Geier MR
    Clin Exp Rheumatol; 2002; 20(6):767-71. PubMed ID: 12508767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.